The Polish senior citizen's medicine cabinet is usually pathological, we have a great deal of unnecessary drugs and pathosupplementation. There is also a problem with so-called invalidating pharmacotherapy, when, as a result of drug complications and side effects, seniors feel increasingly...
Access to treatment of hemato-oncology diseases needs further optimization. More reimbursement decisions are needed. With access to modern first-line drugs, patients get much better treatment outcomes and are much less burdened by the therapeutic process. This is also a real benefit for the...
W poniedziałek 19 lutego kolejne posiedzenie Rady Przejrzystości.
Are we treating acute myeloid leukemia in Poland according to international guidelines? How do targeted therapies change the treatment outlook? Prof. Agnieszka Wierzbowska of the Department of Hematology at the Medical University of Lodz says.
A Notice of the Minister of Health dated February 7, 2024 on the list of medicinal products, foodstuffs for special nutritional purposes and medical devices at risk of unavailability on the territory of the Republic of Poland has been published in the Official Journal of the Ministry of Health.
A decision on the morning-after pill will be made at the next session of the Sejm. The Confederation filed a motion during the second reading to reject the draft amendment to the Pharmaceutical Law, so the project must be dealt with by the Health Committee.
Acute myeloid leukemia is one of the relatively rare hematopoietic malignancies. We discuss the diagnostic and therapeutic challenges with Professor Lidia Gil of the Department of Hematology and Bone Marrow Transplantation at the Poznan University of Medical Sciences.
- Anesthesiology takes patient safety as its starting point. Anyone undergoing sedation or anesthesia must first and foremost be safe," Professor Janusz Andres, president of the Polish Society of Anesthesiology and Intensive Care, told Medexpress in an interview.
– Program lekowy sprawił, że pacjenci są właściwie zaopiekowani i diagnozowani. Dzięki ostatniej aktualizacji mamy w programie nową cząsteczkę, farycymab, która pozwala istotnie wydłużyć odstępy czasowe między zgłaszaniem się pacjentów do ośrodka – powiedziała prof. Małgorzata Figurska z Kliniki...
Within the Polish Association of Employers of the Pharmaceutical Industry - National Drug Manufacturers, the section Biological Drugs for Poland has been separated, which will deal with activities aimed at increasing Polish patients' access to biological therapies and developing their production...
February 5 next meeting of the Transparency Council.
The WHO European Region has seen an alarming increase in measles cases in 2023, with more than 42,200 cases. Hospitalization rates have also increased in many countries.
The Ombudsman inquired whether the ministry could have had access to detailed health data.
During the session, it was scheduled:Preparation of an opinion on the use of the medicinal product BIMERVAX - vaccine against COVID-19 (recombinant, with adjuvant).Preparation of a position paper on the legitimacy of qualifying the service "Monitoring of cardiac function and therapy of dangerous...
Changes in the composition of the Presidium of the Commission. Consideration of information on the operation of the Medical Fund in 2020-2023 and the status of publicly funded infrastructure investments - presented by the Minister of Health.
A meeting was held at the headquarters of the Patient Ombudsman on the issue of penalties imposed by the NFZ on doctors who prescribe milk replacer to children suffering from severe food allergies. The meeting was attended by Minister Bartlomiej Chmielowiec - the Ombudsman for Patients' Rights,...
In 2023, an impressive number of nearly 800 million packages of medicines were verified and dispensed in the Polish Drug Authenticity Verification System, while maintaining an average weekly number of 15.2 million. Handling efficiency in the previous year averaged 40.5 million transactions per...
The product in question is a drop used for, among other things, polyps and related symptoms of reduced nasal patency. Production of this specific was most likely completed in May 2023.
A Draft Regulation of the Minister of Health amending the Regulation on defining the list of health care services requiring the establishment of a separate financing method has been submitted for consultation.
January 22 next meeting of the Transparency Council.
On Monday, January 15, the next meeting of the Transparency Council.
Patients with plasmocytic myeloma have gained access to first-line treatment with daratumumab in the DRd regimen (in combination with lenalidomide and dexamethasone). Patients and their physicians have been waiting for this reimbursement decision.
Interview with Prof. Marek Rękas, national consultant for ophthalmology
January 8 next meeting of the Transparency Council.
Takeda Pharma sp. z o.o. in Poland has appointed Sameha Rafla as CEO.
As of January, a decision will take effect that will significantly improve first-line treatment options for plasmocytic myeloma. However, this raises reimbursement challenges for patients with relapsed disease. The most pressing need is to include the KDd regimen in second-line reimbursement.
We discuss the treatment of severe asthma with Prof. Maciej Kupczyk, president of the Polish Society of Allergology (Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz).
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has published a positive opinion for omaweloxolone, the first therapeutic solution to treat Friedreich's ataxia, a rare neurodegenerative disease.
People struggling with allopecia experience stigma and have huge problems with self-acceptance. This is all the more dangerous because the onset of the disease most often occurs during puberty, when not only the body matures, but also the psyche of a young person is formed. Medical advances have...
© 2023 Medexpress. All Rights Reserved
